•
magAssist, a firm based in Suzhou, China, has announced that it has received breakthrough device designation from the US Food and Drug Administration (FDA) for its artificial heart product, the NyokAssist interventional ventricular assist device (VAD). The company highlights that this designation recognizes the cutting-edge design features of its innovative…